Exact Mass: 502.0562

Exact Mass Matches: 502.0562

Found 34 metabolites which its exact mass value is equals to given mass value 502.0562, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

SCHEMBL5184816

Bis(1L-myo-inositol)-3,1-phosphate 1-phosphate

C12H24O17P2 (502.0489)


   

Garciduol B

2-[2,4-dihydroxy-3-(3-hydroxybenzoyl)-6-methoxyphenyl]-1,4,5-trihydroxy-9H-xanthen-9-one

C27H18O10 (502.09)


Garciduol B is found in fruits. Garciduol B is a constituent of Garcinia dulcis (mundu). Constituent of Garcinia dulcis (mundu). Garciduol B is found in fruits.

   
   

SCHEMBL13922309

9,11,13,20,22-pentahydroxy-5,16,24-trimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(26),2,4(25),5,8,10,12,14(28),15(27),16,19,21,23-tridecaene-7,18-dione

C31H18O7 (502.1052)


   
   

Ethyliden-6,6-bis(2,3,7-trihydroxynaphthazarin)

Ethyliden-6,6-bis(2,3,7-trihydroxynaphthazarin)

C22H14O14 (502.0384)


   

Garciduol B

2-{2,4-dihydroxy-3-[(3-hydroxyphenyl)carbonyl]-6-methoxyphenyl}-1,4,5-trihydroxy-9H-xanthen-9-one

C27H18O10 (502.09)


   

Benzyl 3,5-bis(benzyloxy)-4-bromobenzoate

Benzyl 3,5-bis(benzyloxy)-4-bromobenzoate

C28H23BrO4 (502.078)


   

1,3-Benzodithiol-2-yltriphenyl phosphonium tetrafluoroborate

1,3-Benzodithiol-2-yltriphenyl phosphonium tetrafluoroborate

C25H20BF4PS2 (502.0773)


   

3,5-Bis(3,5-dimethoxybenzyloxy)benzyl Bromide

3,5-Bis(3,5-dimethoxybenzyloxy)benzyl Bromide

C25H27BrO6 (502.0991)


   

uranyl nitrate hexahydrate

uranyl nitrate hexahydrate

H12N2O14U (502.0796)


   

Tafamidis meglumine

Tafamidis meglumine

C21H24Cl2N2O8 (502.091)


C87006 - Pharmacological Chaperone

   

Quinoxaline-2-carboxyl adenylate

Quinoxaline-2-carboxyl adenylate

C19H17N7O8P- (502.0876)


   
   

3-[acetyl(hydroxy)amino]propyl-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyphosphinic acid

3-[acetyl(hydroxy)amino]propyl-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyphosphinic acid

C14H24N4O12P2 (502.0866)


   

4-Chloro-3-(trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-Chloro-3-(trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C24H14ClF3N2O3S (502.0366)


   

N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C21H24F2N2O6S2 (502.1044)


   

4-[4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]-2-hydroxybenzoic acid

4-[4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]-2-hydroxybenzoic acid

C23H22N2O7S2 (502.0868)


   

beta-D-Galp3S-(1->4)-beta-D-Glcp6S

beta-D-Galp3S-(1->4)-beta-D-Glcp6S

C12H22O17S2 (502.0298)


A glycosylglucose derivative that is beta-lactose bearing two sulfo substituents at position 3 of the galactosyl residue and position 6 of the glucose.

   

beta-D-Galp6S-(1->4)-beta-D-Glcp6S

beta-D-Galp6S-(1->4)-beta-D-Glcp6S

C12H22O17S2 (502.0298)


A glycosylglucose derivative that consists of 6-sulfated beta-D-glucose having a 6-sulfated beta-D-galactosyl residue attached at position 4.

   

6-[(3-Carboxy-3-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propanoyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[(3-Carboxy-3-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propanoyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C20H22O15 (502.0959)


   

2-[(3-{4-[(6-Carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-3-methoxyphenyl}prop-2-enoyl)oxy]-3-hydroxybutanedioic acid

2-[(3-{4-[(6-Carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-3-methoxyphenyl}prop-2-enoyl)oxy]-3-hydroxybutanedioic acid

C20H22O15 (502.0959)


   

bis(1L-myo-inositol) 3,1-phosphate 1-phosphate

[(2S,3R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl] [(1S,2R,3S,4S,5R,6R)-2,3,4,6-tetrahydroxy-5-phosphonooxycyclohexyl] hydrogen phosphate

C12H24O17P2 (502.0489)


   

GSK2647544

GSK2647544

C24H18ClF3N4O3 (502.1019)


GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages[1].

   

SMS1-IN-1

SMS1-IN-1

C23H23BrN2O4S (502.0562)


SMS1-IN-1, compound SAPA 1j, is a novel and the most potent sphingomyelin synthase 1 (SMS1) inhibitor with an IC50 value of 2.1 μM. SMS1-IN-1 has the potential for the treatment of atherosclerosis[1].

   

2,3,5,6,8-pentahydroxy-7-[1-(1,3,4,6,7-pentahydroxy-5,8-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione

2,3,5,6,8-pentahydroxy-7-[1-(1,3,4,6,7-pentahydroxy-5,8-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione

C22H14O14 (502.0384)


   

16-chloro-17-(chloromethyl)-4,10-dihydroxy-6,15-dimethoxy-6-methyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione

16-chloro-17-(chloromethyl)-4,10-dihydroxy-6,15-dimethoxy-6-methyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione

C24H16Cl2O8 (502.0222)


   

7,9,13,20,24,26-hexahydroxynonacyclo[16.12.0.0²,¹⁵.0³,¹².0⁴,²⁹.0⁵,¹⁰.0⁶,²⁷.0²¹,³⁰.0²³,²⁸]triaconta-1(18),2,4(29),5(10),6,8,12,14,19,21(30),23,25,27-tridecaene-11,22-dione

7,9,13,20,24,26-hexahydroxynonacyclo[16.12.0.0²,¹⁵.0³,¹².0⁴,²⁹.0⁵,¹⁰.0⁶,²⁷.0²¹,³⁰.0²³,²⁸]triaconta-1(18),2,4(29),5(10),6,8,12,14,19,21(30),23,25,27-tridecaene-11,22-dione

C30H14O8 (502.0689)


   

4-bromo-2-{2-[3-bromo-6-(2-chloro-1-hydroxyethyl)-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol

4-bromo-2-{2-[3-bromo-6-(2-chloro-1-hydroxyethyl)-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol

C19H33Br2ClO3 (502.0485)


   

[(1s)-2-(3,5-dibromo-4-methoxyphenyl)-1-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium

[(1s)-2-(3,5-dibromo-4-methoxyphenyl)-1-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium

[C18H26Br2N5O2]+ (502.0453)


   

2,5,6,7,8-pentahydroxy-3-[1-(3,5,6,7,8-pentahydroxy-1,4-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione

2,5,6,7,8-pentahydroxy-3-[1-(3,5,6,7,8-pentahydroxy-1,4-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione

C22H14O14 (502.0384)


   

10,23-dichloro-16-methoxyhexacyclo[13.9.3.1²,⁶.0⁹,¹⁴.0¹⁸,²⁶.0²¹,²⁵]octacosa-1(24),2(28),3,5,9,11,13,15(27),16,18(26),19,21(25),22-tridecaene-3,13,24-triol

10,23-dichloro-16-methoxyhexacyclo[13.9.3.1²,⁶.0⁹,¹⁴.0¹⁸,²⁶.0²¹,²⁵]octacosa-1(24),2(28),3,5,9,11,13,15(27),16,18(26),19,21(25),22-tridecaene-3,13,24-triol

C29H20Cl2O4 (502.0739)


   

(1r,2r,4r)-4-bromo-2-{2-[(2s,3r,6s)-3-bromo-6-[(1s)-2-chloro-1-hydroxyethyl]-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol

(1r,2r,4r)-4-bromo-2-{2-[(2s,3r,6s)-3-bromo-6-[(1s)-2-chloro-1-hydroxyethyl]-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol

C19H33Br2ClO3 (502.0485)